The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALKERMES PLC | COM | G01767105 | 6,207 | 257,554 | SH | SOLE | 257,554 | 0 | 0 | |||
| BIOGEN INC | COM | 09062X103 | 28,696 | 123,785 | SH | SOLE | 123,785 | 0 | 0 | |||
| BIONTECH SE-ADR | COM | 09075V102 | 10,631 | 132,293 | SH | SOLE | 132,293 | 0 | 0 | |||
| CARDINAL HEALTH INC | COM | 14149Y108 | 21,400 | 217,656 | SH | SOLE | 217,656 | 0 | 0 | |||
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 16,230 | 1,251,338 | SH | SOLE | 1,251,338 | 0 | 0 | |||
| EXELIXIS INC | COM | 30161Q104 | 37,691 | 1,677,393 | SH | SOLE | 1,677,393 | 0 | 0 | |||
| JAZZ PHARMACEUTICALS PLC | COM | G50871105 | 11,642 | 109,076 | SH | SOLE | 109,076 | 0 | 0 | |||
| MURAL ONCOLOGY PLC | COM | G63365103 | 236 | 75,057 | SH | SOLE | 75,057 | 0 | 0 | |||
| REGENERON PHARMACEUTICALS | COM | 75886F107 | 8,254 | 7,853 | SH | SOLE | 7,853 | 0 | 0 | |||
| SANOFI-ADR | COM | 80105N105 | 7,464 | 153,832 | SH | SOLE | 153,832 | 0 | 0 | |||
| TARO PHARMACEUTICAL INDUS | COM | M8737E108 | 27,954 | 650,089 | SH | SOLE | 650,089 | 0 | 0 | |||
| UNITED THERAPEUTICS CORP | COM | 91307C102 | 37,655 | 118,208 | SH | SOLE | 118,208 | 0 | 0 | |||
| VANDA PHARMACEUTICALS INC | COM | 921659108 | 3,741 | 662,166 | SH | SOLE | 662,166 | 0 | 0 | |||